お知らせ

Enhancing T cell receptor stability in rejuvenated iPSC-derived T cells improves their use in cancer immunotherapy.

業績番号:2018-2

A.Minagawa T.Yoshikawa, T.Yasukawa, M.Kunimoto, S.Iriguchi, M.Takiguchi, Y.Kassai, E.Imai, Y.yasui, Y.Kawai, R.Zhang, H.Miyoshi, M.Nnakanishi A.Watanabe, A.Hayashi, K.Kawana, T.Fujii, T.Nakatsura and S.Kaneko

Enhancing T cell receptor stability in rejuvenated iPSC-derived T cells improves their use in cancer immunotherapy.

Cell Stem Cell 23(6); 850:858; 2018.

30449714

https://doi.org/10.1016/j.stem.2018.10.005